{
  "trial_id": "NCT03677349",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Patient eligible for reconstructive surgery after carcinological excision following a decision taken in a multidisciplinary consultation",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Scheduled post-operative radiotherapy",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Coverage by the Social Security system",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Capacity to provide informed consent",
      "label": "met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Post-traumatic substance loss (ballistic autolysis)",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Surgical or anesthetic contraindication (physiological age, other proposed therapeutic options)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Pregnant or breastfeeding woman",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Subject incapable of full age or deprived of liberty",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Indication for chemotherapy with highly neurotoxic agents",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Inability to complete questionnaires or express feelings during the examination",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has CLL and large cell transformation, with a history of treatment with FCR, PCR, R-CVP, and Campath. He has had some response to therapy, but also some progression.",
  "_meta": {
    "topic_id": "8",
    "trial_id": "NCT03677349",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}